Taking into consideration that conventional markers such as glomerular filtration rate (GFR) or NT-proBNP have failed to correspond to acute HF outcome, we purposely attempted to incorporate a biomarker that correlates to water and extracellular volume handling without being affected by glomerular function, which may be variously aggravated in advanced HF patients. The gene discussed is NPPB; the disease is hydrops fetalis.